News Center

2020.05.08

Moving toward becoming a powerhouse in pharmaceutical equipment is an urgently needed breakthrough for the industry.

The domestic pharmaceutical machinery market is growing at an astonishing pace. By 2016, it is projected to triple—or even triple again—compared to the current size of 15 billion yuan. Under the supervision of the new healthcare reform and the new Five-Year Plan, the pharmaceutical equipment industry will clearly benefit. The high technological content of these devices means significantly reduced costs and substantial economic benefits. However, we must acknowledge that currently, many Chinese enterprises are still at the stage of imitating, improving, and combining existing technologies; they have yet to reach the level of true innovation or surpass their global counterparts. In the pharmaceutical equipment industry, few companies are increasing their investment in equipment technology. This situation within the industry calls for immediate change. For a long time, due to production standards consistently lagging behind international ones, Chinese pharmaceutical equipment has faced criticism from the international market regarding quality standards, and several trade disputes have even arisen as a result. Encouragingly, with the implementation of the new GMP guidelines, China’s pharmaceutical industry has achieved integration between international and domestic production standards, and this will further accelerate its entry into the global market. The pharmaceutical machinery industry is a specialized field that integrates pharmaceutical technology, biotechnology, chemical engineering, mechanical and manufacturing technologies, acoustics, optics, automated control, and computer applications. As such, its development is closely linked to various industries across the board. How to achieve qualitative transformation from quantitative accumulation, and how to make the leap from being a large producer of pharmaceutical equipment to becoming a powerful one—these represent significant challenges hindering the industry’s further development, and they are issues that urgently need to be addressed. It is up to industry insiders themselves to find solutions. Industry insiders suggest that companies lacking strong technological and financial backing could collaborate with pharmaceutical design institutes and research institutions, participating in the development of new drugs and process improvements at pharmaceutical plants. By strengthening regular equipment maintenance and providing customer training, these companies can win more clients. (Excerpted from China Pharmaceutical Network)

2024.12.20

Leadership Care | A delegation from the National People's Congress Visits and Conducts Research at Qiaoming Medical for Guidance and Inspection

On the morning of December 19, 2024, a delegation from the National People's Congress (NPC) paid a field visit to Qiaoming Medical. The delegation was led by Cao Hongming, member of the NPC Standing Committee, Vice Chairman of the Overseas Chinese Affairs Committee, and Vice Chairman of the Central Committee of the Zhi Gong Party. This visit aimed to gain an in-depth understanding of the economic and social development situation in the Overseas Chinese Management Zone of Aoshan Town and to convey the CPC Central Committee’s care and concern for the vast number of returned overseas Chinese and their families. Xu Li, a second-level inspector at the Legislative Affairs Office of the NPC Overseas Chinese Affairs Committee, accompanied the delegation. Also joining the visit were leaders including Han Jun, member of the Jiangxi Provincial NPC Standing Committee and Director of the Foreigners, Ethnic Minorities, and Religious Affairs Working Committee; Xiong Qinxian, Deputy Director of the Yichun Municipal NPC Standing Committee; Jin Biao, Secretary of the Shanggao County Party Committee; and Li Guogang, Director of the Shanggao County NPC Standing Committee. Wu Jianghao, Secretary of the Party Branch and head of Qiaoming Medical, along with Wu Xiaotong, representative of management and manager of the Technical Department, warmly welcomed the delegation and presented a detailed report.

< 123 >

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Copyright © 2025 Jiangxi Qiaoming Medical Device Co., Ltd. | SEO

Support:  300.cn

Business license